This is an Untapped Market
People In the United States Suffer From Osteoarthritis
14-55
Age Range: Aimed at Younger Patients Suffering from OA
The Growing Hip Preservation Market is worth Billions
Our Technology?
Expertise and Innovation
Sign up for Business News
Questions
About the
Technology?
Expertise and Innovation
Sign up for Business News
News
Breakthrough Device Designation from the FDA
We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
October Newsletter
The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
In WRAL Techwire
CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022. According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...
News
Breakthrough Device Designation from the FDA
We are thrilled to announce that we just received a Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for our novel hip cartilage repair technology. The intent of the Breakthrough Devices Program1 is to help patients have...
October Newsletter
The October issue of the CytexOrtho newsletter covers our progression toward clinical trials, discussions with the FDA, and our new CRP award from NIH! If you would like to receive a copy of our future newsletters, be sure to sign up for our mailing lists via the...
In WRAL Techwire
CytexOrtho is in the news! WRAL Techwire featured a Startup Spotlight article about CytexOrtho on Monday, August 8th, 2022. According to WRAL: “Startup Spotlight is a regular feature in WRAL Techwire, bringing attention to promising emerging companies across the...